On episode #63 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 8/29/24 – 9/13/24.
Host: Daniel Griffin and Sara Dong
Click arrow to play
Download Puscast 063 (22 MB .mp3, 37 min)
Subscribe (free): Apple Podcasts, RSS, email
Become a patron of Puscast!
Links for this episode
- Viral
- Postacute Sequelae of COVID (PASC or Long COVID): An Evidenced-Based Approach (OFID)
- A New Orthonairovirus Associated with Human Febrile Illness (NEJM)
- Farmed fur animals harbour viruses with zoonotic spillover potential(Nature)
- A Cross-Sectional Evaluation of the Virtual Outpatient Management of People With Mpox (OFID)
- A randomized, placebo-controlled, dose-escalation phase I/II multicenter trial of low-dose cidofovir for BK polyomavirus nephropathy (Transplant Infectious Disease)
- A Decade of Chronic Norovirus Infection Surveillance at the NIH Clinical Research Center: Clinical Characteristics, Molecular Epidemiology, and Replication (JID)
- Bacterial
- FDA clears new Lyme disease test (CIDRAP)
- Lyme ImmunoBlot Receives FDA Clearance(Accesswire)
- The Utilization Of Echocardiography In Children With Staphylococcus aureus Bacteremia (Journal of Pediatric Infectious Diseases Society)
- Duration of antibiotic therapy for multidrug resistant Pseudomonas aeruginosa pneumonia: is shorter truly better?(BMC Infectious Diseases)
- Short Versus Long Antibiotic Duration in Streptococcus pneumoniae Bacteremia (OFID)
- FDA Marketing Authorization Enables Increased Access to First Step of Syphilis Diagnosis
- FDA)
- Clinical impact of pleural fluid Streptococcus pneumoniae PCR testing in children with complicated pneumonia (CID)
- Duration of antibiotic therapy for multidrug resistant Pseudomonas aeruginosa pneumonia: is shorter truly better? (BMC Infectious Diseases)
- Short Versus Long Antibiotic Duration in Streptococcus pneumoniae Bacteremia (OFID)
- Fungal
- The Last of US Season 2 (YouTube)
- Incidence and risk factors for invasive fungal infections in patients initiating TNF-alpha inhibitors for inflammatory bowel disease and rheumatoid arthritis (CID)
- Parasitic
- Intestinal helminth infection impairs vaccine-induced T cell responses and protection against SARS-CoV-2 in mice(Science Translational Medicine)
- Miscellaneous
- Successful Treatment of Refractory Cutaneous Protothecosis With MAT2203, an Oral Lipid Nanocrystal Formulation of Amphotericin B (OFID)
- The Impact of Infectious Diseases Scholarly Mentorship on Subsequent Infectious Disease Fellowship Application (CID)
Music is by Ronald Jenkees
Information on this podcast should not be considered as medical advice.
Leave a Reply